Direct Biologics Reveals Successful Outcomes from EXIT COVID

AUSTIN, Texas, April 6, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a lifesaving mesenchymal stem cell (MSC) derived extracellular vesicle (EV) platform

Related Keywords

Texas , United States , California , San Antonio , Vikram Sengupta , Kostenloser Wertpapierhandel , University Of California , Order Fulfillment Center , Acute Respiratory Distress Syndrome , Chief Medical , Sascha Sengupta , Associate Chief Medical , Direct Biologics , Direct , Iologics , Eveals , Uccessful , Outcomes , Rom , Exit , Covid , Hase , Linical , Trial ,